---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-013944"
form_type: "8-K"
ticker: "FZMD"
cik: "0000319016"
company_name: "Fuse Medical, Inc."
filed_at: "2022-04-08T23:59:59+00:00"
generated_at: "2026-06-26T08:35:12.554517+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Fuse Medical appoints Lawrence S. Yellin as CFO, Treasurer, and board member

## Summary
- Lawrence S. Yellin appointed CFO, Treasurer, and board member effective April 4, 2022.
- Yellin's annual base salary $200,000; he is a CPA with MBA from Pace University.
- John S. Gross ceased providing interim CFO services on same date.
- Yellin will serve as audit committee financial expert; term until next annual meeting.
- No family relationships or material interests disclosed per Item 404(a).

## SEC filing metadata
- accession: 0001564590-22-013944
- form_type: 8-K
- ticker: FZMD
- cik: 0000319016
- company_name: Fuse Medical, Inc.
- filed_at: 2022-04-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/319016/000156459022013944/0001564590-22-013944-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/319016/000156459022013944/fzmd-8k_20220404.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-013944
- JSON: https://secwatch.observer/filing/0001564590-22-013944.json
- Plain text: https://secwatch.observer/filing/0001564590-22-013944.txt

## Key facts
- Executive change
  Lawrence S. Yellin was appointed as Chief Financial Officer and Treasurer at Fuse Medical, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Treasurer
  source text: Effective April 4, 2022, the Board of Directors of the Company (the “Board”) has appointed Lawrence S. Yellin as Chief Financial Officer (CFO) and Treasurer of the Company and as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/319016/000156459022013944/0001564590-22-013944-index.htm
- Executive change
  Lawrence S. Yellin was appointed as Director at Fuse Medical, Inc..
  - Action: appointed
  - Role: Director
  source text: Effective April 4, 2022, the Board of Directors of the Company (the “Board”) has appointed Lawrence S. Yellin as Chief Financial Officer (CFO) and Treasurer of the Company and as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/319016/000156459022013944/0001564590-22-013944-index.htm
- Executive change
  John S. Gross departed as Interim Chief Financial Officer at Fuse Medical, Inc..
  - Action: ceased providing interim CFO services
  - Role: Interim Chief Financial Officer
  source text: Effective April 4, 2022, John S. Gross ceased providing the Company with interim CFO services pursuant to the Company’s engagement agreement with CFO Consulting Partners, LLC.
  evidence_url: https://www.sec.gov/Archives/edgar/data/319016/000156459022013944/0001564590-22-013944-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.